[go: up one dir, main page]

FR2705233B1 - Nouvelles formes galéniques permettant la chronolibération différentielle d'associations de micronutriments utilisés en diététique et/ou thérapeutique. - Google Patents

Nouvelles formes galéniques permettant la chronolibération différentielle d'associations de micronutriments utilisés en diététique et/ou thérapeutique.

Info

Publication number
FR2705233B1
FR2705233B1 FR9306172A FR9306172A FR2705233B1 FR 2705233 B1 FR2705233 B1 FR 2705233B1 FR 9306172 A FR9306172 A FR 9306172A FR 9306172 A FR9306172 A FR 9306172A FR 2705233 B1 FR2705233 B1 FR 2705233B1
Authority
FR
France
Prior art keywords
dietetics
associations
therapeutics
dosage forms
new dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9306172A
Other languages
English (en)
Other versions
FR2705233A1 (fr
Inventor
Costanzo Jacques Di
Pierre Moreau
Marx Pernin
Bernard Marty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MICROLITHE SA
ATHELIAPHARM SA
Original Assignee
MICROLITHE SA
ATHELIAPHARM SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MICROLITHE SA, ATHELIAPHARM SA filed Critical MICROLITHE SA
Priority to FR9306172A priority Critical patent/FR2705233B1/fr
Publication of FR2705233A1 publication Critical patent/FR2705233A1/fr
Application granted granted Critical
Publication of FR2705233B1 publication Critical patent/FR2705233B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
FR9306172A 1993-05-14 1993-05-14 Nouvelles formes galéniques permettant la chronolibération différentielle d'associations de micronutriments utilisés en diététique et/ou thérapeutique. Expired - Fee Related FR2705233B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9306172A FR2705233B1 (fr) 1993-05-14 1993-05-14 Nouvelles formes galéniques permettant la chronolibération différentielle d'associations de micronutriments utilisés en diététique et/ou thérapeutique.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9306172A FR2705233B1 (fr) 1993-05-14 1993-05-14 Nouvelles formes galéniques permettant la chronolibération différentielle d'associations de micronutriments utilisés en diététique et/ou thérapeutique.

Publications (2)

Publication Number Publication Date
FR2705233A1 FR2705233A1 (fr) 1994-11-25
FR2705233B1 true FR2705233B1 (fr) 1996-07-12

Family

ID=9447379

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9306172A Expired - Fee Related FR2705233B1 (fr) 1993-05-14 1993-05-14 Nouvelles formes galéniques permettant la chronolibération différentielle d'associations de micronutriments utilisés en diététique et/ou thérapeutique.

Country Status (1)

Country Link
FR (1) FR2705233B1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2773484B1 (fr) * 1998-01-09 2001-03-30 Pierre Moreau Nouvelles compositions a effet synergique entre micronutriments et substances d'origine vivante
DK1667665T3 (da) * 2003-09-03 2009-05-04 Pharmaton Sa Kapsler indeholdende pellets med aktivt stof, som har forskellige frigivelsesprofiler
BRPI0414818A (pt) * 2003-09-26 2006-11-14 Nestec Sa composição nutricional com ácidos graxos insaturados e elementos traço

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2532177A1 (fr) * 1982-08-30 1984-03-02 Being Well Products Inc Complement nutritionnel a zones de liberation determinees et son procede de fabrication
FR2600890B1 (fr) * 1986-07-03 1990-02-23 Moreau Pierre Nouvelles compositions riches en oligoelements et leurs procedes de fabrication.
US4895725A (en) * 1987-08-24 1990-01-23 Clinical Technologies Associates, Inc. Microencapsulation of fish oil
GB2212396A (en) * 1987-12-18 1989-07-26 Procter & Gamble Dietary supplement comprising calcium and delayed release coated iron

Also Published As

Publication number Publication date
FR2705233A1 (fr) 1994-11-25

Similar Documents

Publication Publication Date Title
BR9407799A (pt) Composição de matéria método de tratamento e composição farmaceutica
ATE198894T1 (de) 1,5 benzodiazepinoderivate mit cck- antagonisierender und oder agonisierender wirkung
BR1100824A (pt) Composto e composição farmacêutica
FR2623810B2 (fr) Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FI962589L (fi) 2,4-disulfofenyylibutyylinitroni, sen suolat ja niiden käyttö farmaseuttisina aineina
IT8423086A0 (it) Composizione farmaceutica o dietetica ad elevata attivita'antitrombotica e antiarteriosclerotica.
MX9202839A (es) 4-aminoquinolinas y composiciones farmaceuticas de las mismas.
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
FI990387A7 (fi) Tienopyrimidiinijohdannaiset, niiden valmistus ja käytt"
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
FR2709679B1 (fr) Compositions aqueuses concentrées d'alkylpolyglycosides et leurs utilisations.
BR8702978A (pt) Aplicacao de 3-acilamino-1,2,4-triazois e/ou de 1-acil-3-amino-1,2,4-triazois
FR2712191B1 (fr) Composition pharmaceutique ou diététique associant du ginseng et du guarana.
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
FR2705671B1 (fr) Nouveaux dérivés de l'hydroxybiphényle, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2598312B1 (fr) Aerateur sinusien permanent trans-nasal en double " t "
FR2705233B1 (fr) Nouvelles formes galéniques permettant la chronolibération différentielle d'associations de micronutriments utilisés en diététique et/ou thérapeutique.
FI956353L (fi) Farmaseuttiset valmisteet ja niiden käyttö etenkin neurodegeneratiivisten sairauksien hoidossa
FR2709964B1 (fr) Compositions pharmaceutiques antivirales proposées dans le traitement du SIDA et de l'Herpès.
FR2659556B1 (fr) Compositions a base d'arnica, et leurs utilisations notamment dans des compositions pharmaceutiques ou cosmetiques.
FR2684299B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride.
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
FR2709063B1 (fr) Composition à base d'un ou de plusieurs éléments transuraniens - et en particulier de plutonium - pour la prévention et le traitement homéopathiques de l'infection par le V.I.H..
DE69012958D1 (de) Fibrinolytisches Protein und Herstellungsweise dafür.
EP0655919A4 (fr) Traitement d'infections virales chez l'homme.

Legal Events

Date Code Title Description
ST Notification of lapse
RN Application for restoration
FC Favourable decision of inpi director general on an application for restauration.
ST Notification of lapse

Effective date: 20060131